Antibiotics: Tetracyclines and Erythromycin

  • Gerd Plewig
  • Albert M. Kligman


Starting with sulfonamides and penicillin each new antibiotic and chemotherapeutic drug has been enthusiastically welcomed as an effective acne treatment. This exemplifies the difficulties of therapeutic evaluations, for penicillin is ineffective and sulfonamides are hardly helpful. It is almost impossible to compare results from different investigators despite the efforts made to obtain objective data by controlled studies.


Nephrogenic Diabetes Insipidus Propionibacterium Acne Tetracycline Hydrochloride Acne Patient Erythromycin Estolate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ad Hoc Committee Report (1975) Systemic antibiotics for treatment of acne vulgaris: efficacy and safety. Arch Dermatol 111:1630–1636CrossRefGoogle Scholar
  2. Baer RL, Leshaw SM, Shalita AR (1976) High-dose tetracycline therapy in severe acne. Arch Dermatol 112:479–481PubMedCrossRefGoogle Scholar
  3. Blank H, Cullen SI, Catalano PM (1968) Photosensitivity studies with demethylchlortetracycline and doxycycline. Arch Dermatol 97:1–2PubMedCrossRefGoogle Scholar
  4. Esterly NB, Furey NL, Flanagan LE (1978) The effect of antimicrobial agents on leucocyte Chemotaxis. J Invest Dermatol 70:51–55PubMedCrossRefGoogle Scholar
  5. Frost P, Weinstein GD, Gomez EC (1972) Phototoxic potential of minocycline and doxycycline. Arch Dermatol 105:681–683PubMedCrossRefGoogle Scholar
  6. Hubbell CG, Hobbs ER, Rist T, White JW Jr (1982) Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Arch Dermatol 118:989–992PubMedCrossRefGoogle Scholar
  7. Kurokawa J, Nishijima S, Asada Y (1988) The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation. J Dermatol 15:149–154PubMedGoogle Scholar
  8. Leyden JJ, McGinley KJ, Kligman AM (1982) Tetracycline and minocycline treatment. Effects on skin-surface lipid levels and Propionibacterium acnes. Arch Dermatol 118:19–22PubMedCrossRefGoogle Scholar
  9. Noble WC (1990) Topical and systemic antibiotics: is there a rationale? Semin Dermatol 9:250–254PubMedGoogle Scholar
  10. Olafsson JH, Gudgeirsson J, Eggertsdottir GE, Kristjansson F (1989) Doxycycline versus minocycline in the treatment of acne vulgaris: a double-blind study. J Derm Treat 1:15–19CrossRefGoogle Scholar
  11. Plewig G, Schöpf E (1975) Anti-inflammatory effects of antimicrobial agents: an in vivo study. J Invest Dermatol 65:532–536PubMedCrossRefGoogle Scholar
  12. Puhvel SM, Reisner RM (1972) Effect of antibiotics on the lipases of Corynebacterium acnes in vitro. Arch Dermatol 106:45–49PubMedCrossRefGoogle Scholar
  13. Simmons JJ, Morales A (1980) Minocycline and generalized cutaneous pigmentation. J Am Acad Dermatol 3:244–247CrossRefGoogle Scholar
  14. Adams SJ, Cunliffe WJ, Cooke EM (1985) Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of patients and their relatives. J Invest Dermatol 85:35–37PubMedCrossRefGoogle Scholar
  15. Cohen ML, Wong ES, Falkow S (1982) Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak. Antimicrob Agents Chemother 21:210–215PubMedGoogle Scholar
  16. Cooksey RC, Baldwin JN (1985) Relatedness of tetracycline resistance plasmids among species of coagulase-negative staphylococci. Antimicrob Agents Chemother 27:234–238PubMedGoogle Scholar
  17. Eady EA, Ross JI, Cove JH, Holland KT, Cunliffe WJ (1989) Macrolide — lincosamide — streptogram-in B (MLS) resistance in cutaneous Propionibacteria: definition of phenotypes. J Antimicrob Chemother 23:493–502PubMedCrossRefGoogle Scholar
  18. Eady EA, Cove JH, Holland KT, Cunliffe WJ (1989) Erythromycin resistant Propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 121:51–57PubMedCrossRefGoogle Scholar
  19. Eady EA, Holland KT, Cunliffe WJ (1982) Should topical antibiotics be used for the treatment of acne vulgaris? Br J Dermatol 107:235–246PubMedCrossRefGoogle Scholar
  20. Kerry Williams SM, Noble WC (1988) Plasmids in coryneform bacteria of human origin. J Appl Bacteriol 64:475–482CrossRefGoogle Scholar
  21. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM (1983) Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 8:41–45PubMedCrossRefGoogle Scholar
  22. Noble WC (1990) Topical and systemic antibiotics: is there a rationale? Semin Dermatol 9:250–254PubMedGoogle Scholar
  23. Rahman M, Noble WC, Cookson B (1987) Mupirocin-resistant Staphylococcus aureus. Lancet 2:387–388CrossRefGoogle Scholar
  24. Richmond MH, Linton KB (1980) The use of tetracycline in the community and its possible relation to the excretion of tetracycline-resistant bacteria. J Antimicrob Chemother 6:33–41PubMedCrossRefGoogle Scholar
  25. Westh H, Jensen BL, Rosdahl VT, Prag J (1989) Development of erythromycin-resistance in Staphylococcus aureus as a consequence of high erythromycin consumption. J Hosp Infect 14:107–115PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Gerd Plewig
    • 1
  • Albert M. Kligman
    • 2
  1. 1.Dermatologische Klinik und PoliklinikUniversität MünchenMünchen 2Germany
  2. 2.School of MedicineUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations